Dr. Xiang Zhang will be presenting his work "New Concept of Bioresorbable Polymer-based Ceramic Hybrids for Cardiovascular Stent Applications" at Materials Science Conference.
Prof. & Dr. Xiang Zhang, Royal
Society Industry Fellow of University of Cambridge, has over 34 years combined
academia (17 years) and industrial (17 years) experience in advanced materials
science and technology, an expert in polymer and polymeric hybrid materials
science and technology. Prof. Zhang is also Head of the Lucideon Cambridge
School of Advanced Materials and Head of Medical Materials and Devices. He is
the author of three books “Inorganic Biomaterials”, “Inorganic Controlled
Release Technology” and “Science and Principles of Biodegradable and
Bioresorbable Medical Polymers - Materials and Properties”. As a materials
scientist, he is passionate on “Science for Industry “and believes fundamental
but applied sciences are the keys to industry R&D and problem solving.
Prof. Zhang undertook his PhD and postdoctoral research at Cranfield University
where he studied materials physics and nano/micro-mechanics and
nano/micro-fracture mechanics of polymeric hybrid (organic and inorganic)
materials. After spending a further four years on research for industrial
applications, he was awarded an industrial fellowship at the University of
Cambridge in 1995, where he carried out research on fundamental nanomechanisms
of polymeric ductile to brittle transitions, which is first time in the world
ever employing synchrotron SAXS, WAXS (wide angle and small angel X-ray
scattering) to study in situ deformation and fracture down to nanometre scales,
the results of which lead to completion of ductile to brittle transition theories
in view of nano-mechanics and nano-fracture mechanics. Prof. Zhang’s industry
experience was gained in leading international healthcare companies, where, as
Principal Scientist/Technologist, his work covered almost all aspects of
medical materials and devices from R&D and manufacturing support to failure
analysis and QC. Prior to joining Lucideon, Prof. Zhang worked as Director of a
technology company, in the field of nano-conductive materials and diagnostic
medical devices.
The abstract of his presentation can be found below.
This presentation will introduce new theories and
industry practice for design and development of polymer-based ceramic
hybrids. The evolution from pure
polymer-based medical devices to polymer-based ceramic hybrids is to meet unmet
market needs for better clinical performance over existing systems. There are many factors that can affect
medical implant performance and, historically, most of them have been well
studied, such as bioactivities and biocompatibility. In this presentation, new concept will be
mainly addressing issue surround biomechanics, biofracture mechanucs and
biofunctionality for design and development of new hybrid biomaterials for
implant applications. It will report the
principles on formulations for two type of the new systems. One family is of biodegradable and
bioresorbable hybrids and 2nd is of non-biodegradable hybrids. It will be followed by design and development
of medical devices in view of industry practice with clinical performance
considerations of medical devices. The
main topics covered in the presentation include: (a) New concepts and synthetic
pathway of polymer-based ceramic hybrids; (b) Nano/Micro mechanics and
nano/micro fracture mechanics; (c) Industry practice – two case studies will be
used to demonstrate on how to design and develop polymer-based ceramic hybrid
biomaterials and relevant processing technology for the applications of medical
implants. Cardiovascular stent, as an
example is traditionally made of metal such as Bare Metal Stents (BMS) or with
drug coatings, i.e. Drug Eluting Stents (DES).
There are, however, clinical complications associated with these
technologies, such as, early stage restenosis, very late thrombosis and risk
associated with revision surgery. In
light of these challenges research focus has turned to the development of
bioresorbable vascular scaffold (BVS) technologies.
We have developed new bioresorbable polymer-based
ceramic stent that has been reinforced resorbable therapeutic cardiovascular
stent to address the known limitations of cardiovascular technologies. We have developed a bioresorbable stent with
intrinsic toughness for handling and deployment via balloon angioplasty, radial
strength, controlled drug-release technology to suppress restenosis and surface
functionalisation to promote endothelialisation to reduce risk of thrombosis.
We present the novel synthetic polymer-ceramic composites developed as
candidate stent-core materials, both their preparation and the characterisation
of their mechanical behaviour, in vitro degradation will be presented.
For more details, please visit: http://materialsresearch.conferenceseries.com/